Eptifibatide

NDC 70436-163 · Slate Run Pharmaceuticals, LLC

Generic nameeptifibatide

Dosage formINJECTION

RouteINTRAVENOUS

Active ingredient(s)EPTIFIBATIDE

Strength.75 mg/mL

Pharmacologic classDecreased Platelet Aggregation [PE], Platelet Aggregation Inhibitor [EPC]

Marketing categoryANDA

Packages

70436-163-80 — 100 mL in 1 VIAL (70436-163-80)

FDA lists these products with the same active ingredient.

0338-9558 — Eptifibatide, 25021-408 — eptifibatide, 52958-040 — Eptifibatide, 52958-402 — Eptifibatide, 55150-218 — Eptifibatide, 55150-219 — Eptifibatide, 55150-220 — Eptifibatide, 67457-629 — eptifibatide, 67457-630 — eptifibatide, 67457-631 — eptifibatide, 70436-026 — eptifibatide, 70436-027 — eptifibatide, 70436-162 — eptifibatide, 71288-412 — Eptifibatide, 71288-413 — Eptifibatide, 72078-025 — eptifibatide, 72078-026 — eptifibatide, 72078-027 — eptifibatide, 83634-300 — eptifibatide, 83634-301 — eptifibatide

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.